These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1616659)

  • 21. Vasoactive intestinal polypeptide (VIP) secretion and refractory diarrhea in patients with AIDS or AIDS-related complex (ARC).
    Manfredi R; Vezzadini P; Fanti MP; Chiodo F
    Scand J Infect Dis; 1994; 26(1):55-7. PubMed ID: 8191241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
    Simon DM; Cello JP; Valenzuela J; Levy R; Dickerson G; Goodgame R; Brown M; Lyche K; Fessel WJ; Grendell J
    Gastroenterology; 1995 Jun; 108(6):1753-60. PubMed ID: 7768380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of fusidic acid on Tanzanian patients with AIDS.
    Jørgensen AF; Mwakyusa D; Cegielski P; Gøtzsche P; Hørding M; Lallinger G; Mbaga I; Pallangyo K; Richter C; Shao J
    AIDS; 1990 Oct; 4(10):1037-8. PubMed ID: 2261122
    [No Abstract]   [Full Text] [Related]  

  • 24. Variable efficacy of octreotide in diabetic diarrhea.
    Virally-Monod ML; Guillausseau PJ; Assayag M; Tielmans D; Ajzenberg C; Vasseur-Mallus S; Imberty C; Warnet A
    Diabetes Metab; 1996 Oct; 22(5):356-8. PubMed ID: 8896998
    [No Abstract]   [Full Text] [Related]  

  • 25. Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea. Effects of treatment with octreotide.
    Manfredi R; Vezzadini P; Costigliola P; Ricchi E; Fanti MP; Chiodo F
    AIDS; 1993 Feb; 7(2):223-6. PubMed ID: 8466684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E; Hidalgo M; Hornedo J; Cortés-Funes H
    Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
    Cello JP; Grendell JH; Basuk P; Simon D; Weiss L; Wittner M; Rood RP; Wilcox CM; Forsmark CE; Read AE
    Ann Intern Med; 1991 Nov; 115(9):705-10. PubMed ID: 1929038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS diarrhea: new kid on the paraffin-block.
    Flemmer M; Oldfield EC
    Am J Gastroenterol; 1996 Feb; 91(2):402-3. PubMed ID: 8607525
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacologic agents used for nutritional disorders of HIV/AIDS.
    Rosen GH
    J Physicians Assoc AIDS Care; 1995 Jan; 2(1):30-2. PubMed ID: 11362199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
    Walker JJ; Kaplan DS
    Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.
    Füessl HS; Zoller WG; Kochen MM; Bogner JR; Heinrich B; Matuschke A; Goebel FD
    Klin Wochenschr; 1989 Apr; 67(8):452-5. PubMed ID: 2724869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic diarrhoea in adults in the tropics: a practical approach to management.
    Harries AD; Beeching NJ
    Trop Doct; 1991 Apr; 21(2):56-60. PubMed ID: 1871878
    [No Abstract]   [Full Text] [Related]  

  • 33. SMS 201-995, a somatostatin analogue, and diarrhea in the acquired immunodeficiency syndrome (AIDS).
    Robinson EN; Fogel R
    Ann Intern Med; 1988 Oct; 109(8):680-1. PubMed ID: 2901819
    [No Abstract]   [Full Text] [Related]  

  • 34. Octreotide-induced acute pancreatitis in a patient with acquired immunodeficiency syndrome.
    Gradon JD; Schulman RH; Chapnick EK; Sepkowitz DV
    South Med J; 1991 Nov; 84(11):1410-1. PubMed ID: 1948240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of severe AIDS-associated diarrhea with the somatostatin analog octreotide].
    Oehler R; Loos U
    Med Klin (Munich); 1993 Jan; 88(1):45-7. PubMed ID: 8437531
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of long-acting somatostatin in refractory diarrhea in 2 patients with AIDS].
    Routy JP; Blanc AP; Latreille J; Phaneuf D; Neemeh JA; Monte M; Beaulieu R; Legendre F
    Ann Med Interne (Paris); 1989; 140(8):737-8. PubMed ID: 2576501
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness of a somatostatin analog in the treatment of chronic severe diarrhea caused by Cryptosporidium].
    Casals A; Lorente L; Jou B; Clotet A
    Med Clin (Barc); 1989 Mar; 92(9):358-9. PubMed ID: 2565994
    [No Abstract]   [Full Text] [Related]  

  • 38. Octreotide in the management of diarrhea induced by graft versus host disease.
    Ippoliti C; Neumann J
    Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.
    Farthing MJ
    Gut; 1994; 35(3 Suppl):S5-10. PubMed ID: 8206397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin treatment for cryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS).
    Cook DJ; Kelton JG; Stanisz AM; Collins SM
    Ann Intern Med; 1988 May; 108(5):708-9. PubMed ID: 2895991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.